Cargando…
Safety and Outcomes of Intravenous Thrombolytic Therapy in Ischemic Stroke Patients with COVID-19: CASCADE Initiative
BACKGROUND: There is little information regarding the safety of intravenous tissue plasminogen activator (IV-tPA) in patients with stroke and COVID-19. METHODS: This multicenter study included consecutive stroke patients with and without COVID-19 treated with IV-tPA between February 18, 2019, to Dec...
Ejemplares similares
-
Low-dose versus standard-dose alteplase for intravenous thrombolysis in patients with acute ischemic stroke in Iran: Results from the safe implementation of treatments in stroke registry
por: Sadeghi-Hokmabadi, Elyar, et al.
Publicado: (2021) -
Stroke Care Trends During COVID-19 Pandemic in Zanjan Province, Iran. From the CASCADE Initiative: Statistical Analysis Plan and Preliminary Results
por: Ghoreishi, Abdoreza, et al.
Publicado: (2020) -
Outcome predictors in anterior and posterior ischemic strokes: a study based on the Iranian SITS registry
por: Jalali, Nazanin, et al.
Publicado: (2023) -
N-acetylcysteine (NAC) in neurological disorders: mechanisms of action and therapeutic opportunities
por: Bavarsad Shahripour, Reza, et al.
Publicado: (2014) -
Cerebral Vasomotor Reactivity in COVID-19: A Narrative Review
por: Ghotbi, Zahra, et al.
Publicado: (2023)